Effects of Fenofibrate on Cardiovascular (CVD) Events in Patients with Type 2 Diabetes Mellitus (DM) after Adjustment for Statin Use and Other Drugs: the FIELD Study

Effects of Fenofibrate on Cardiovascular (CVD) Events in Patients with Type 2 Diabetes Mellitus (DM) after Adjustment for Statin Use and Other Drugs: the FIELD Study

Bibliographic Details
Main Authors:	Simes, J, Voysey, M, O'Connell, R, Best, J, Scott, R, Glasziou, P, Pardy, C, Ehnholm, C, Byth, K, Keech, A
Format:	Conference item
Published:	2008

Similar Items

Larger Effects of Fenofibrate on CVD in Marked Diabetic Dyslipidemia Are Not Explained by Higher Use of Statin Therapy: The FIELD Study
by: Simes, R, et al.
Published: (2009)

A novel method to adjust efficacy estimates for uptake of other active treatments in long-term clinical trials.
by: Simes, J, et al.
Published: (2010)

Correction: A Novel Method to Adjust Efficacy Estimates for Uptake of Other Active Treatments in Long-Term Clinical Trials.
by: John Simes, et al.
Published: (2010-01-01)

A novel method to adjust efficacy estimates for uptake of other active treatments in long-term clinical trials.
by: John Simes, et al.
Published: (2010-01-01)

Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study.
by: Davis, T, et al.
Published: (2011)

Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481].
by: Scott, R, et al.
Published: (2005)

Effects of fenofibrate on cardiovascular events in patients with diabetes, with and without prior cardiovascular disease: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
by: Tonkin, A, et al.
Published: (2012)

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.
by: Keech, A, et al.
Published: (2005)

Statins and diabetes - Authors' reply
by: Kearney, P, et al.
Published: (2008)

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial.
by: Rajamani, K, et al.
Published: (2009)

Statins and diabetes - Reply
by: Kearney, P, et al.
Published: (2008)

Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes
by: Januszewski, Andrzej S., et al.
Published: (2021)

Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes
by: Andrzej S. Januszewski, et al.
Published: (2021-09-01)

The need for a large-scale trial of fibrate therapy in diabetes: The rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]
by: Barter, P, et al.
Published: (2004)

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
by: Mihaylova, B, et al.
Published: (2012)

INCREASING STATIN USE IN DIABETICS FOR CVD PREVENTION
by: Karsh Gaurav, et al.
Published: (2021-09-01)

Glycemic control over 5 years in 4,900 people with type 2 diabetes: real-world diabetes therapy in a clinical trial cohort.
by: Best, J, et al.
Published: (2012)

Benefits of reducing LDL cholesterol among 18,686 patients with diabetes: Meta-analysis of 14 radomized trials of a statin versus control
by: Kearney, P, et al.
Published: (2006)

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.
by: Kearney, P, et al.
Published: (2008)

Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid
by: Elisavet Moutzouri, et al.
Published: (2010-06-01)

Lack of adjustment for nutrition and undiagnosed Diabetes Mellitus (DM) type 2 in retrospective studies evaiuating the link between DM type 2 and atypical antipsychotics
by: Cerri, K, et al.
Published: (2004)

The relationship of coffee consumption and CVD risk factors in elderly patients with T2DM
by: Hossein Sayed Ghavami, et al.
Published: (2021-05-01)

Fenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemia
by: Peter Alagona Jr
Published: (2010-05-01)

A comparison of standard gamble, time trade-off, and adjusted time trade-off scores.
by: Martin, A, et al.
Published: (2000)

Simulation of quality-adjusted survival in chronic diseases: an application in type 2 diabetes.
by: Hayes, A, et al.
Published: (2011)

Pleiotropic effects of fenofibrate: focus on type 2 diabetes mellitus
by: Alexander Sergeevich Ametov, et al.
Published: (2014-12-01)

Long-term cardiovascular risks and statin treatment impact on socioeconomic inequalities: microsimulation model
by: Wu, R, et al.
Published: (2023)

Fenofibrate and statin therapy, compared with placebo and statin, slows the development of retinopathy in type 2 diabetes patients of 10 years duration: the ACCORD study.
by: Matthews, DR
Published: (2011)

Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study
by: Mihaylova, B, et al.
Published: (2024)

Statins for people at low risk of cardiovascular disease reply
by: Mihaylova, B, et al.
Published: (2012)

Using the EQ-5D index score as a predictor of outcomes in patients with type 2 diabetes.
by: Clarke, P, et al.
Published: (2009)

Effect of fenofibrate on progression of diabetic retinopathy
by: Preiss, D, et al.
Published: (2024)

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
by: Baigent, C, et al.
Published: (2005)

Investigating The Association Of Apolipoprotein E (Apoe) Gene Polymorphism And Its Associated Factors To Cardiovascular Disease (Cvd) In Type 2 Diabetes Mellitus (T2dm) Patients
by: Muzaidi, Nur Alya Syamimie
Published: (2022)

Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant datasets
by: Mihaylova, B, et al.
Published: (2024)

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy.
by: Emberson, J, et al.
Published: (2012)

Effects of fenofibrate in patients with type 2 diabetes mellitus complicated by diabetic neuropathy
by: Olga Nikolaevna Tkacheva, et al.
Published: (2010-03-01)

Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling study
by: Mihaylova, B, et al.
Published: (2024)

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised controlled trials of statins (vol 366, pg 1267, 2005)
by: Baigent, C, et al.
Published: (2008)

Can self-rated health scores be used for risk prediction in patients with type 2 diabetes?
by: Hayes, A, et al.
Published: (2008)